Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
NCT03937817 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2026-05-01
Summary
Background:
Blood disorders like sickle cell disease and malaria affect many people around the world. Researchers want to learn more about blood disorders. To do this, they need to collect biological samples from people with blood disorders. They also need to collect samples from healthy people.
Objective:
To collect samples to use for research on blood disorders.
Eligibility:
People ages 18-70 who have blood disorders. Healthy volunteers without blood disorders are also needed.
Design:
Participants will be screened with a medical history, physical exam, and blood and urine tests.
Participants will give one or more samples. They will give them over 5 years. They can choose not to give any of the samples:
Saliva: Participants will spit into a tube. They may also have the inside of their mouth swabbed.
Urine: Participants will urinate into a cup.
Blood and blood waste products: Blood will be taken through a needle in the participant s arm.
Fat samples: An area on the participant s belly or buttock will be numbed. A small cut will be made into the skin and a small piece of fat removed.
Mucus and cells from the lungs: The participant will be sedated. A flexible tube will be inserted through the nose or mouth into the lung airways. These participants will also have a physical exam, chest x-ray, and heart tests after the procedure.
Conditions
- Malaria
- Human Physiology
- Alpha and Beta Thalassemia
- Sickle Cell Disease
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Hans C Ackerman, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-09-25
- Primary Completion
- 2029-03-31
- Completion
- 2029-03-31
Countries
- United States
Study Locations
More Related Trials
-
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
NCT00528203 ·Status: TERMINATED
-
The Genetics and Functional Basis of Inherited Platelet, White Blood Cell, Red Blood Cell, and Blood Clotting Disorders.
NCT00230165 ·Status: RECRUITING
-
Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia
NCT05910853 ·Status: TERMINATED
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
NCT05660265 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings
NCT03619798 ·Status: UNKNOWN
-
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
NCT06313398 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 ·Status: COMPLETED
-
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
NCT06546670 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research
NCT03876821 ·Status: COMPLETED
-
Living With Sickle Cell Disease in the COVID-19 Pandemic
NCT04417673 ·Status: COMPLETED
-
COVID-19 Vaccine Response in Sickle Cell Disease
NCT05139992 ·Status: COMPLETED
-
Bone Marrow for Hemoglobinopathy Research
NCT00669305 ·Status: COMPLETED
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])
NCT00529061 ·Status: TERMINATED
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
SCRIPT: Sickle Cell Risk in Pregnancy Tool
NCT06529042 ·Status: ENROLLING_BY_INVITATION
-
Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical Care
NCT03167450 ·Status: COMPLETED
-
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
NCT06071377 ·Status: RECRUITING
-
Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease
NCT03977532 ·Status: COMPLETED ·Phase: NA
-
ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19
NCT06831799 ·Status: COMPLETED
-
Transfusion Treatment in Patients With SCD
NCT03397017 ·Status: COMPLETED
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
NCT05153967 ·Status: RECRUITING
-
Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell Anemia
NCT00001716 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
NCT03132324 ·Status: TERMINATED ·Phase: PHASE1
-
Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease
NCT00012545 ·Status: COMPLETED